MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Dyskinesia and bradykinesia severity patterns in Parkinson’s disease using a wearable sensor

    D. van Wamelen, T. Bendriss-Otiko, A. Podlewska, V. Leta, C. Lazcano Ocampo, D. Trivedi, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To determine if dyskinesia and bradykinesia severity has a diurnal pattern in Parkinson’s disease (PD) using wearable sensor data. Background: Diurnal fluctuations in PD…
  • MDS Virtual Congress 2020

    The role of attention networks in walking in Parkinson’s disease

    R. Drake, G. Eskes (Halifax, NS, Canada)

    Objective: To better understand how different attention networks contribute to walking. Background: Parkinson’s disease (PD) is often characterized by effortful, fall-prone walking. PD can also…
  • MDS Virtual Congress 2020

    Object and action naming test in cognitive subtypes in nondemented patients with Parkinson´s disease

    A. Kušnírová, Z. Košutzká, M. Hajdúk, M. Králová, M. Pápayová, M. Egryová, P. Valkovič, Z. Cséfalvay (Bratislava, Slovakia)

    Objective: The aim of our study was to identify more homogenous profiles of patients with Parkinson´s disease (PD) without cognitive decline and to compare language…
  • MDS Virtual Congress 2020

    Premature Cognitive Decline in Young Veterans with mTBI: A Possible Prodromal Signature of Early Stage Parkinson’s Disease

    V. Nejtek, M. Salvatore, R. James, H. Alphonso (Fort Worth, TX, USA)

    Objective: To investigate the hypothesis that young veterans with (+) mTBI will show premature cognitive decline that is similar to executive functioning of Parkinson’s disease…
  • MDS Virtual Congress 2020

    Cognitive function and quality of life in Parkinson’s disease: A cross-sectional study

    Y.L Tang, X.L Liang, LL. Han, J.T Yu, J. Wang (Shanghai, China)

    Objective: We aimed to determine how the cognitive domains affect quality of life (QoL) in different cognitive states in PD. Background: Parkinson’s disease with mild…
  • MDS Virtual Congress 2020

    The study of the role of genetic risk factors in levodopa-induced dyskinesia development in Russian patients with Parkinson’s disease: a pilot study

    G. Akhmadeeva, I. Khidiyatova, I. Gilyazova, A. Baitimerov, G. Tayupova, R. Magzhanov (Ufa, Russian Federation)

    Objective: The aim of our study is to search for genetic risk factors for the development of motor side effects of dopaminergic therapy, such as…
  • MDS Virtual Congress 2020

    Virtual Assessment of LRRK2 Carriers to Optimize Research in Parkinson Disease (VALOR-PD): A Comparison to Traditional Cohorts

    S. Jensen-Roberts, T. Myers, K. Amodeo, S. Sharma, R. Alcalay, E. Dorsey, R. Holloway, R. Schneider (Rochester, NY, USA)

    Objective: To compare a national virtual cohort of LRRK2 G2019S carriers, identified via a personal genetics company, to existing traditional cohorts. Background: Advancements in personal…
  • MDS Virtual Congress 2020

    Biomarker Discovery in Parkinson’s disease using Machine Learning on Public Multi-omic Datasets: A Pilot Study

    M. Makarious, H. Iwaki, C. Blauwendraat, H. Leonard, S. Hashemi, J. Kim, K. Van Keuren-Jensen, D. Craig, E. Appelmans, L. Smolensky, M. Bookman, A. Singleton, F. Faghri, M. Nalls (Bethesda, MD, USA)

    Objective: In this study, we use machine learning (ML) as a framework for biomarker studies to assess if multiple modalities in the same model perform…
  • MDS Virtual Congress 2020

    The ROPAD (Rostock International Parkinson’s Disease Study) study: Towards defining the genetic epidemiology of the disease

    V. Skrahina, H. Gaber, T. Förster, T. Usnich, N. Schell, P. Bauer, X. Bogdanovic, E. Vollstedt, N. Brüggemann, I. Csoti, M. Kasten, N. Koleva-Alazeh, C. Beetz, C. Klein, A. Rolfs (Rostock, Germany)

    Objective: ROPAD is an international, multicenter, epidemiological study that aims at a better understanding of the contribution of genetics to Parkinson’s disease (PD) based on…
  • MDS Virtual Congress 2020

    Type-3 Metabotropic Glutamate Receptors and Parkinson’s Disease: Preclinical Studies and Human Genetics

    M. Alborghetti, L. Di Menna, A. Traficante, V. Bruno, J. Monn, F. Nicoletti, F.E Pontieri, E. Bianchini, G. Spalletta, M. Borro, M. Simmaco, G. Battaglia (Rome, Italy)

    Objective: In a MPTP mice model of toxicological parkinsonism we examine whether the presence or absence of mGlu3 receptors is neuroprotective. We also  evaluted association…
  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley